RELEVANT REFERENCES:
1. Shanshal M, Ahmed HS. COVID-19 and Herpes Simplex Virus Infection: A Cross-Sectional Study. Cureus. 2021 Sep 16;13(9):e18022.
2. Chen, J, Song, J, Dai, L, Post, SR, Qin, Z. SARS-CoV-2 infection and lytic reactivation of herpesviruses: a potential threat in the postpandemic era? J Med Virol. 2022; 94: 5103- 5111.
3. Malavige, G.N., Jeewandara, C. & Ogg, G.S. Dengue and COVID-19: two sides of the same coin. J Biomed Sci 29, 48 (2022).
4. Alla D, Alla S, Vempati R, et al. (November 25, 2022) Dengue & COVID-19: A Comparison and the Challenges at Hand. Cureus 14(11): e31877.
5. Patil SV, Bhadake M, Acharya A. ‘Dengue-COVID-19 overlap’: Is it an ‘antigenic mimicry’ or coexistent two different viral genotypic diseases? Prospective, observational study in tertiary care setting in India. Electron J Gen Med. 2022;19(6):em400.
6. Li, K., Li, L., Wang, X. et al. Comparative analysis of clinical features of SARS-CoV-2 and adenovirus infection among children. Virol J 17, 193 (2020).
7. Shafiee A, Aghajanian S, Athar MMT, Gargari OK. Epstein-Barr virus and COVID-19. J Med Virol. 2022 Sep;94(9):4040-4042.
8. Manoharan S, Ying LY. Epstein Barr Virus Reactivation during COVID-19 Hospitalization Significantly Increased Mortality/Death in SARS-CoV-2(+)/EBV(+) than SARS-CoV-2(+)/EBV(-) Patients: A Comparative Meta-Analysis. Int J Clin Pract. 2023
9. David B Villafuerte, Olga Lavrynenko, Rayan Qazi, Marco F Passeri, Fernando L Sanchez. Chronic active Epstein-Barr exacerbated by COVID-19 co-infection. Volume 122, P976-978, September 2022. International Journal of Infectious Diseases.
10. Rohrhofer, J., Graninger, M., Lettenmaier, L., Schweighardt, J., Gentile, S.A., Koidl, L., Ret, D., Stingl, M., Puchhammer-Stöckl, E. and Untersmayr, E. (2023), Association between Epstein-Barr-Virus reactivation and development of Long-COVID fatigue. Allergy, 78: 297-299.
11. Chen J, Li F, Tian J, Xie X, Tang Q, Chen Y, Ge Y. Varicella zoster virus reactivation following COVID-19 vaccination in patients with autoimmune inflammatory rheumatic diseases: A cross-sectional Chinese study of 318 cases. J Med Virol. 2023 Jan;95(1):e28307.
12. Martinez-Reviejo R, Tejada S, Adebanjo GAR, Chello C, Machado MC, Parisella FR, Campins M, Tammaro A, Rello J. Varicella-Zoster virus reactivation following severe acute respiratory syndrome coronavirus 2 vaccination or infection: New insights. Eur J Intern Med. 2022 Oct;104:73-79.
13. Ronderos D, Omar AMS, Abbas H, Makker J, Baiomi A, Sun H, Mantri N, Choi Y, Fortuzi K, Shin D, Patel H, Chilimuri S. Chronic hepatitis-C infection in COVID-19 patients is associated with in-hospital mortality. World J Clin Cases. 2021 Oct 16;9(29):8749-8762.
14. Somayeh Shokri, Shahab Mahmoudvand. The possibility of hepatitis C reactivation in COVID-19 patients treated with corticosteroids. Annals of Hepatology 27 (2022) 100704
15. Yang, C., An, S., Qiao, B. et al. Exploring the influence of COVID-19 on the spread of hand, foot, and mouth disease with an automatic machine learning prediction model. Environ Sci Pollut Res 30, 20369–20385 (2023).
16. El-Qushayri AE, Reda A, Shah J. COVID-19 and monkeypox co-infection: A rapid systematic review. Front Immunol. 2022 Dec 14;13:1094346.
17. Somayeh Shokri, Shahab Mahmoudvand. The possibility of hepatitis C reactivation in COVID-19 patients treated with corticosteroids. Annals of Hepatology 27 (2022) 100704
18. Brown LB, Spinelli MA, Gandhi M. The interplay between HIV and COVID-19: summary of the data and responses to date. Curr Opin HIV AIDS. 2021 Jan;16(1):63-73.
19. COVID-19 Infection and Anti-Aging Gene Inactivation. Acta Scientific Nutritional Health 4.5 (2020): 01-02.
- Badges
- Science method